Paralief Sinus Tablets Paracetamol 500 mg Pseudoephedrine hydrochloride 30 mg Írország - angol - HPRA (Health Products Regulatory Authority)

paralief sinus tablets paracetamol 500 mg pseudoephedrine hydrochloride 30 mg

chanelle medical - pseudoephedrine hydrochloride; paracetamol - tablet - 500/30 milligram(s) - anilides; paracetamol; sympathomimetics; pseudoephedrine

TRUST SINUS & NASAL DECONGESTANT pseudoephedrine hydrochloride 60 mg tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

trust sinus & nasal decongestant pseudoephedrine hydrochloride 60 mg tablet blister pack

noumed pharmaceuticals pty ltd - pseudoephedrine hydrochloride, quantity: 60 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate - fast temporary relief from a runny nose and reduce the swollen membranes of the nose and sinuses and helping breathe freely.

Ephedrine Hydrochloride 3 mg/ml solution for injection in pre-filled syringe Írország - angol - HPRA (Health Products Regulatory Authority)

ephedrine hydrochloride 3 mg/ml solution for injection in pre-filled syringe

laboratoire aguettant - ephedrine hydrochloride - solution for injection in pre-filled syringe - 3 milligram(s)/millilitre - ephedrine

EPHEDRINE INTERPHARMA ephedrine hydrochloride 30 mg/10 mL solution for injection ampoule Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ephedrine interpharma ephedrine hydrochloride 30 mg/10 ml solution for injection ampoule

interpharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: sodium chloride; sodium citrate; citric acid; water for injections - ephedrine interpharma injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.

BENYLIN DUAL ACTION DRY - PSEUDOEPHEDRINE/DEXTROMETHORPHAN/TRIPROLIDINE Írország - angol - HPRA (Health Products Regulatory Authority)

benylin dual action dry - pseudoephedrine/dextromethorphan/triprolidine

johnson & johnson (ireland) limited - pseudoephedrine hydrochloride ; dextromethorphan hydrobromide ; triprolidine hydrochloride - syrup - 30/10/1.25 milligram - pseudoephedrine, combinations

Ephedrine Hydrochloride Injection (Max Health) Új-Zéland - angol - Medsafe (Medicines Safety Authority)

ephedrine hydrochloride injection (max health)

max health limited - ephedrine hydrochloride 30 mg/ml - solution for injection - 30 mg/ml - active: ephedrine hydrochloride 30 mg/ml excipient: water for injection - indicated in the treatment of hypotension secondary to spinal anaesthesia in adults.

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE- brompheniramine maleate, pseudoephedrine Egyesült Államok - angol - NLM (National Library of Medicine)

brompheniramine maleate, pseudoephedrine hydrochloride, dextromethorphan hydrobromide- brompheniramine maleate, pseudoephedrine

acella pharmaceuticals, llc - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - brompheniramine maleate 2 mg in 5 ml - brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase inhibitors (maois) (see drug interactions ). antihistamines should not be used to treat lower respiratory tract conditions including asthma.

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE- brompheniramine maleate, pseudoephedrine Egyesült Államok - angol - NLM (National Library of Medicine)

brompheniramine maleate, pseudoephedrine hydrochloride, dextromethorphan hydrobromide- brompheniramine maleate, pseudoephedrine

proficient rx lp - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase inhibitors (maois) (see drug interactions ). antihistamines should not be used to treat lower respiratory tract conditions including asthma.

FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCL - fexofenadine hcl and pseudoephedrine hcl  tablet, extended release Egyesült Államok - angol - NLM (National Library of Medicine)

fexofenadine hcl and pseudoephedrine hcl - fexofenadine hcl and pseudoephedrine hcl tablet, extended release

dr.reddy's laboratories limited - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 180 mg - fexofenadine hcl 180 mg and pseudoephedrine hcl 240 mg extended-release tablets (24 hour formulation) are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion.  fexofenadine hcl 180 mg and pseudoephedrine hcl 240 mg extended-release tablets (24 hour formulation) should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology ). fexofenadine hcl 180 mg and pseudoephedrine hcl 240 mg extended-release tablets (24 hour formulation) are contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, fexofenadine hcl 180 mg and pseudoephedrine hcl  240 mg extended-release tablets (24 hour formulation) are contrai